Abstract: The present study attempted to clarify the antihypertensive effect and its mechanism when alinolenic acid (ALA) is administered orally. For this purpose, 1 mL of flaxseed oil, which is rich in ALA, and high oleic safflower oil was administered orally to spontaneously hypertensive rats (SHR) of a control and an ALA group on days 1 and 5. Systolic blood pressure was measured on day 1, and blood and liver were collected on day 5. Four hours after the oral administration on day 1, systolic blood pressure of the ALA group was lower than that of the control group. Levels of plasma vasodilators, such as prostaglandin I 2 metabolite, nitric oxide metabolites, and bradykinin, in the ALA group were significantly higher than those in the control group, but levels of vasoconstrictors, such as angiotensin II and thromboxane A 2 metabolite, did not differ significantly. It is known that bradykinin induces prostaglandin I 2 and nitric oxide. The present study shows that ALA reduced the systolic blood pressure of SHR, and its mechanism may be related to increases of prostaglandin I 2 and nitric oxide through bradykinin stimulation.
INTRODUCTION
Today we know that n-3 fatty acids are essential for normal growth and development and have many beneficial effects. Many epidemiological and animal studies have suggested that dietary a-linolenic acid (ALA) prevents and improves hypertension [1] [2] [3] [4] [5] [6] [7] [8] [9] . In a recent epidemiological study, Djoussé et al. 9) reported that dietary ALA is associated with a lower prevalence of hypertension and lower systolic blood pressure in Caucasian subjects.
It is known that blood pressure is regulated by the vasoconstrictors and vasodilators. Rupp et al. 10) reported that ALA supplementation increased prostaglandin I 2 (PGI 2 ) which is one of the vasodilators. However, it is not clear why PGI 2 is increased by ALA supplementation. A recent study reported that an agonist of endothelial B2 kinin receptors, such as bradykinin (BK), increases calcium ions with a subsequent activation of constitutive cyclooxygenase-1 (COX-1) and nitric oxide synthase-3 (NOS-3) 11) . This is followed by an immediate release of PGI 2 and NO. Therefore, we expected that the antihypertensive effect of ALA may relate to BK stimulation because BK stimulation induces PGI 2 synthesis.
Our previous study indicated that ALA have an antihypertensive effect in Japanese subjects with high-normal blood pressure and mild hypertension 12) . However, antihypertensive mechanisms of ALA intake are not elucidated enough. The aim of the present study is to clarify the antihypertensive mechanisms of ALA administration. For this purpose, systolic blood pressure, plasma vasodilators, and vasoconstrictors were assessed in seven-week-old spontaneously hypertensive rats (SHR) which had been administrated ALA-rich flaxseed oil (FSO).
EXPERIMENTAL

1
All animals were treated in accordance with the guideli '
le SHR of the Izumo colony (SHR/Izm, Japan SLC, Inc., Hamamatsu, Shizuoka, Japan) were individually housed in stainless steel wire cages and allowed free access to sterilized water. The temperature of the animal room was set at 23 1 , with a humidity of 50 5% and illumination from 08:00 to 20:00 h. The animals were also allowed free access to a commercial stock diet (PicoLab Rodent Diet 20, PMI Nutrition International, Richmond, IN, U.S.A.).
The rats, weighing 150-170 g, were randomized into two groups (n = 8). The rats were administrated orally 1 mL (density is 0.92 g/mL) of high oleic safflower oil (HOSO, The Nisshin Oillio Group, Ltd, Tokyo, Japan) or FSO (The Nisshin Oillio Group, Ltd, Tokyo, Japan) on day 1 and day 5. The fatty acid composition of the test lipids is shown in . HOSO and FSO were administered to the control and ALA groups, respectively. On day 1, the systolic blood pressure was measured 4 hours after oral administration. Four hours after oral administration on day 5, the blood was collected from the inferior vena cava. EDTA 2Na was used as an anticoagulant, and plasma was separated by centrifugation at 2,700 g for 15 min at 4 . All the animals were killed by cardiac puncture.
2
Systolic blood pressure was measured using a non-preheating, non-invasive blood pressure monitor for mice and rats (MK-2000, Muromachi Kikai Co., Ltd, Tokyo, Japan).
3
Plasma 6-keto-prostaglandin F 1a (6-keto-PGF 1a ) and thromboxane B 2 levels were analyzed by means of enzyme immunoassay kits (Cayman Chemicals Co. Ann Arbor, MI, U.S.A.). 6-keto-PGF 1a and thromboxane B 2 are stable metabolites of PGI 2 (also called prostacyclin) and thromboxane A 2 , respectively. Plasma BK level was analyzed by means of an enzyme immunoassay kit (Peninsula Laboratories Inc., San Carlos, CA, U.S.A.). Plasma angiotensin II level was measured using a radioimmunoassay kit (SRL Inc., Tokyo, Japan). Plasma NO metabolite (NO 2 and NO 3 ) level was analyzed by means of a colorimetric assay kit: NO 2 /NO 3 Assay kit-C II (Dojindo Laboratories, Kumamoto, Japan). NO 2 and NO 3 are stable metabolites of NO after deproteinization of plasma by filtration using Centricon ® (Millipore Co., Billerica, MA, U.S.A.).
4
Total liver lipids were extracted using the method described by Bligh and Dyer 13) . Total liver lipids and test lipids were saponified in 0.5 mol/L sodium hydroxide in methanol for 7 min at 100 to liberate free fatty acids, and cooled on ice. After saponification, 2 mL of 14% boron trifluoride in methanol was added to a fatty acid sodium salts solution, and methylated for 5 min at 100 . Fatty acid methyl esters were extracted using n-hexane. Fatty acid derivatives were analyzed by gas-liquid chromatography using a GC-2014 (Shimadzu Corporation, Kyoto, Japan) equipped with a capillary column (OMEGAWAX™ 250, 30 m-long, 0.25 mm internal diameter, 0.25 mm thickness, Supelco,
5
' t p , Inc., Tokyo, Japan) was used for all of the statistical analyses.
RESULTS
Body weight did not differ significantly between the control and ALA groups (data not shown). Four hours after oral administration, systolic blood pressure in the ALA group was significantly lower than that in the control group ( ). In the plasma, 6-keto-PGF 1a level in the ALA group was significantly higher than that in the control group ( ). Thromboxane B 2 level did not differ significantly ( ). BK level in the ALA group was significantly higher than that in the control group ( ). Regarding angiotensin II level, no significant difference was seen between the control and ALA groups ( ). NO metabolites (NO 2 and NO 3 ) level in the ALA group was significantly higher than that in the control group ( ). shows the fatty acid composition of the total liver lipids in the SHR/Izm. The proportions of oleic acid and arachidonic acid in the ALA group were significantly lower than those in the control group. The proportions of ALA and eicosapentaenoic acid (EPA) in the ALA group were significantly higher than those in the control group.
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DISCUSSION
Four hours after oral administration, systolic blood pressure in the FSO group was significantly lower than that in the HOSO group ( ). This result is similar to those reported in previous studies 1, 3, 7, 8) which used rats fed ALA-rich FSO. In the present study, we showed that the oral administration of ALA reduced systolic blood pressure.
Rupp et al. 10) reported that vascular PGI 2 formation was increased by dietary ALA intake in SHR. However, dietary lipid levels in their study differed from those in ours because Rupp et al. 10) added different levels of FSO to the diets. Therefore, because PGI 2 is synthesized from n-6 series fatty acid, the increase of PGI 2 may be caused by the increase of n-6 series linoleic acid from supplementary FSO. This study was performed in such a way that the rats were administered the uniform lipid levels and the same n-6 fatty acid proportion. The present study showed that the plasma 6-keto-PGF 1a level in the ALA group was significantly higher than that in the control group ( ). BK and NO were also elevated by ALA administration ( ). BK has blood pressure-lowering effects that can be induced by secretion of secondary agents. Yamasaki et al. 14) reported that BK stimulation increased cytosolic phospholipase A 2 mRNA and prostaglandin H synthase (same as COX)-1 and 2 mRNAs in human vascular endothelial cells. PGI 2 is synthesized in response to the release of arachidonic acid from phospholipids followed by the transformation of arachidonic acid to PGH 2 by PGH synthase and the subsequent transformation of PGH 2 by PGI 2 synthase. Therefore, PGI 2 might be increased through the increase of BK with oral ALA administration. Gryglewski et al. 11) reported that BK increases Ca 2+ with the subsequent activation of constitutive COX-1 and NOS-3. The increase of NO may be also have been caused by the increase of BK when ALA was administered orally.
Thromboxane B 2 (thromboxane A 2 metabolite) and angiotensin II were not changed by the ALA administration ( and ). Therefore, vasoconstrictors may not play a role in the improvement of hypertension by ALA administration. Angiotensin II conversion and BK degradation are catalyzed by ACE (same as kininase II). Because angiotensin II did not change by following ALA administration, ACE activity might not be changed. The increase of BK may be affected by the increase of BK generation and/or a decrease of BK degradation through endopeptidase and others, but its mechanisms remain unclear.
On day 5, EPA proportion of liver was significantly higher in the ALA group. ALA can be rapidly converted to EPA 15) . Fish oil containing EPA also exert an antihypertensive effect [16] [17] [18] [19] [20] . Knapp and FitzGerald 21) reported that a high dose of fish oil initially increased the formation of vasodilatory prostaglandins (PGI 2 and I 3 ). Therefore, in the present study, EPA converted from ALA may be partly associated with the lowering of systolic blood pressure and the increase of PGI 2 with oral ALA administration.
CONCLUSION
The present study showed a lowering of blood pressure and increases of the levels of vasodilators, such as BK, PGI 2 , and NO, in SHR/Izm with following oral ALA administration. When ALA was administered orally, one of the antihypertensive mechanisms may be related to increases of PGI 2 and NO through BK stimulation. 
